Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Common Equity (2016 - 2025)

Creative Medical Technology Holdings has reported Common Equity over the past 16 years, most recently at $7.5 million for Q4 2025.

  • Quarterly Common Equity rose 18.5% to $7.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2025, up 18.5% year-over-year, with the annual reading at $7.5 million for FY2025, 18.5% up from the prior year.
  • Common Equity was $7.5 million for Q4 2025 at Creative Medical Technology Holdings, up from $5.6 million in the prior quarter.
  • Over five years, Common Equity peaked at $23.0 million in Q2 2022 and troughed at -$2.4 million in Q1 2021.
  • The 5-year median for Common Equity is $8.6 million (2024), against an average of $9.3 million.
  • Biggest five-year swings in Common Equity: skyrocketed 6174.45% in 2022 and later tumbled 45.78% in 2024.
  • Tracing CELZ's Common Equity over 5 years: stood at $10.2 million in 2021, then surged by 55.27% to $15.9 million in 2022, then crashed by 34.8% to $10.3 million in 2023, then tumbled by 38.69% to $6.3 million in 2024, then rose by 18.5% to $7.5 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $7.5 million, $5.6 million, and $6.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.